Showing results (1-10 of 20) with videos related to
Sort By:
Pageof 2
Expert Review of Molecular Diagnostics|August 31, 2016
Exploiting the potential of next-generation sequencing in genomic medicineAnna Maria Pinto, Francesca Ariani, Laura Bianciardi, et al.Transplantation|January 3, 2020
Detection of Cryptic Mosaicism in X-linked Alport Syndrome Prompts to Re-evaluate Living-donor Kidney TransplantationAnna Maria Pinto, Sergio Daga, Chiara Fallerini, et al.Clinical Journal of the American Society of Nephrology : CJASN|June 8, 2022
Digenic Alport SyndromeJudy Savige, Alessandra Renieri, Elisabet Ars, et al.European Journal of Human Genetics : EJHG|October 18, 2024
Slowly progressive autosomal dominant Alport Syndrome due to COL4A3 splicing variantSergio Daga, Lorenzo Loberti, Giulia Rollo, et al.Human Mutation|November 4, 2017
Urine-derived podocytes-lineage cells: A promising tool for precision medicine in Alport SyndromeSergio Daga, Margherita Baldassarri, Caterina Lo Rizzo, et al.European Journal of Human Genetics : EJHG|November 23, 2019
New frontiers to cure Alport syndrome: COL4A3 and COL4A5 gene editing in podocyte-lineage cellsSergio Daga, Francesco Donati, Katia Capitani, et al.European Journal of Human Genetics : EJHG|April 26, 2020
High rate of HDR in gene editing of p.(Thr158Met) MECP2 mutational hotspotSusanna Croci, Miriam Lucia Carriero, Katia Capitani, et al.European Journal of Human Genetics : EJHG|June 17, 2020
AAV-mediated FOXG1 gene editing in human Rett primary cellsSusanna Croci, Miriam Lucia Carriero, Katia Capitani, et al.Genes and Immunity|December 25, 2021
Rare variants in Toll-like receptor 7 results in functional impairment and downregulation of cytokine-mediated signaling in COVID-19 patientsStefania Mantovani, Sergio Daga, Chiara Fallerini, et al.Journal of Hematology & Oncology|August 17, 2021
SELP Asp603Asn and severe thrombosis in COVID-19 malesChiara Fallerini, Sergio Daga, Elisa Benetti, et al.Pageof 2